Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIRM-ACT trial in metastatic adrenocortical carcinoma
2004-001125-20Phase 3Completed
- Sponsor
- San Luigi Gonzaga Hospital
- Start
- Jan 2007
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in adrenal cancer (ACC) comparing Etoposide + Doxorubicin + Cisplatin + Mitotane with Streptozotocin + Mitotane (2 arms). Started Jan 2007; status: completed.
02
Drugs
etoposidedoxorubicincisplatinmitotanestreptozocin
03
Conditions
adrenal cancer (ACC)
Beyond the preview
Go deeper on 2004-001125-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001125-20.